お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
市場調査レポート
商品コード
977669

CAR-T療法の世界市場:2030年までの機会と戦略、COVID-19の影響と回復

CAR-T Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery

出版日: | 発行: The Business Research Company | ページ情報: 英文 242 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.75円
CAR-T療法の世界市場:2030年までの機会と戦略、COVID-19の影響と回復
出版日: 2020年12月21日
発行: The Business Research Company
ページ情報: 英文 242 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートは、世界のCAR-T療法市場について調査しており、市場規模や予測、動向や戦略、成長および抑制要因、COVID-19の影響、用途・標的抗原・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 目次

第3章 図のリスト

第4章 表のリスト

第5章 レポートの構造

第6章 イントロダクション

    • 地域セグメンテーション
    • 用途別セグメンテーション
    • 標的抗原別セグメンテーション

第7章 特徴

  • 市場の定義
  • 標的抗原別市場細分化
    • CD19療法
    • CD22療法
    • BCMA療法
    • その他
  • 用途別市場細分化
    • 急性リンパ芽球性白血病
    • びまん性大細胞型B細胞リンパ腫
    • 濾胞性リンパ腫
    • 慢性リンパ性白血病
    • 多発性骨髄腫
    • その他

第8章 顧客情報

  • 医師の関心
  • CAR-T療法に対する地域腫瘍学者の肯定的な認識
  • 地域腫瘍学者別採用における課題と認識された障壁
  • CART細胞療法後の生活の質の改善

第9章 市場動向と戦略

  • より少ない副作用のための改良されたCAR-T細胞療法
  • 治療を改善するための既製の同種異系CAR-T療法
  • 高悪性度神経膠腫の治療のための次世代CAR-T細胞
  • 将来のCAR-T療法を最適化するための機械学習と人工知能
  • 先端技術のための技術企業との協力
  • を促進するための提携の拡大

第10章 COVID影響分析

  • 世界のCAR-T療法への影響
  • 世界の臨床試験への影響
  • 主要な世界の腫瘍学企業への影響

第11章 世界の市場規模と成長

  • 市場成長:売上実績(2015-2019)
    • 市場成長要因
    • 市場抑制要因
  • 市場成長:売上予測(2019-2023、2025F、2030F)

第12章 市場セグメンテーション

  • 市場売上実績・予測:用途別(2015-2019、2023F、2025F、2030F)
    • びまん性大細胞型B細胞リンパ腫
    • 急性リンパ芽球性白血病
    • 濾胞性リンパ腫
    • 多発性骨髄腫
    • 慢性リンパ性白血病
    • その他
  • 市場売上実績・予測:標的抗原別(2015-2019、2023F、2025F、2030F)
    • CD19
    • BCMA
    • その他の標的抗原
    • CD22

第13章 市場分析:地域/国別

  • 市場実績・予測:地域別売上(2015-2019、2023F、2025F、2030F)
  • 市場実績・予測:国別売上(2015-2019、2023F、2025F、2030F)

第14章 アジア太平洋地域

第15章 西欧

第16章 東欧

第17章 北米

第18章 南米

第19章 中東

第20章 アフリカ

第21章 競合情勢

  • 企業プロファイル
  • Gilead Sciences
    • 企業概要
    • 製品とサービス
    • 事業戦略
    • 財務概要
  • Novartis AG

第22章 パイプライン分析

  • 癌細胞療法の実施中の臨床試験:情勢の比較(2020)
  • がんの種類別:実施中の臨床試験数
  • がんの種類別:実施中の臨床試験数
  • 試験部位別:世界のCAR-T細胞療法
  • 標的別:がんの臨床試験における分子数
  • CAR-T細胞療法パイプライン分析

第23章 主要な合併と買収

  • ResTORbioがAdicetBioと合併
  • Astellas PharmaがXyphosBiosciencesを買収
  • Bristol Myers SquibbがCelgene Corporationを買収
  • Celgene がJunoTherapeuticsを買収
  • Gilead SciencesがCell Design Labsを買収
  • Gilead SciencesがKite Pharmaを買収

第24章 機会と戦略

  • 2023年:最も新しい機会を提供する国
  • 2023年:最も新しい機会を提供するセグメント
  • 2023年:成長戦略
    • 市場動向ベースの戦略
    • 競合他社の戦略

第25章 結論・提言

  • 結論
  • 提言

第26章 付録

目次

CAR-T Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global CAR-T Therapy market.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Gain a global perspective on the development of the market.

Where is the largest and fastest growing market for the CAR-T therapy market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global CAR-T therapy market opportunities and strategies to 2030 report from the Business Research Company answers all these questions and many more.

The report covers the following chapters

  • Executive Summary - The executive summary section of the report gives a brief overview and summary of the report
  • Report Structure - This section gives the structure of the report and the information covered in the various sections.
  • Introduction - The introduction section of the report gives brief introduction about segmentation by geography and segmentation by target antigen and by application.
  • Market Characteristics - The market characteristics section of the report defines and explains the CAR-T therapy market. This chapter also defines and describes products covered in the report.
  • Customer Information - This chapter covers recent customers' trends/preferences in the global CAR-T therapy market
  • Trends And Strategies - This chapter describes the major trends shaping the global CAR-T therapy market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • COVID Impact Analysis - This section provides an insight on how the pandemic is impacting the CAR-T therapy market.
  • Global Market Size And Growth - This section contains the global historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional Analysis - This section contains the historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values and growth and market share comparison by region.
  • Segmentation - This section contains the market values (2015-2030) and analysis for different segments.
  • Regional Market Size and Growth - This section contains the region's market size (2019), historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
  • Competitive Landscape - This section covers details on the competitive landscape of the global CAR-T therapy market, estimated market shares and company profiles for the leading players.
  • Pipeline Analysis - This chapter covers information about the drugs currently in pipeline
  • Key Mergers And Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies - This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Conclusions And Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for CAR-T therapy companies in terms of product offerings, geographic expansion, marketing strategies and target groups.
  • Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

The global CAR-T therapy market is segmented into -

By Target Antigen: CD19 Therapy; CD22 Therapy; BCMA Therapy; Others

By Application: Acute Lymphoblastic Leukemia; Diffuse Large B-Cell Lymphoma; Follicular Lymphoma; Chronic Lymphocytic Leukemia; Multiple Myeloma; Others

Companies Mentioned: Gilead Sciences; Novartis AG

Countries: USA, France, Germany, UK, China, India, Indonesia, Japan, South Korea, Australia, Russia, Brazil

Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. CAR-T Therapy Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction

    • 6.1.1. Segmentation By Geography
    • 6.1.2. Segmentation By Application
    • 6.1.3. Segmentation By Target Antigen

7. CAR-T Therapy Market Characteristics

  • 7.1. Market Definition
  • 7.2. Market Segmentation By Target Antigen
    • 7.2.1. CD19 Therapy
    • 7.2.2. CD22 Therapy
    • 7.2.3. BCMA Therapy
    • 7.2.4. Others
  • 7.3. Market Segmentation By Application
    • 7.3.1. Acute Lymphoblastic Leukemia
    • 7.3.2. Diffuse Large B-Cell Lymphoma
    • 7.3.3. Follicular Lymphoma
    • 7.3.4. Chronic Lymphocytic Leukemia
    • 7.3.5. Multiple Myeloma
    • 7.3.6. Others

8. CAR-T Therapy Market Customer Information

  • 8.1. Interest Of Physicians
  • 8.2. Positive Perception Of Community Oncologists Towards CAR-T Therapy
  • 8.3. Challenges And Perceived Barriers In The Adoption Of CAR-T Therapy by Community Oncologists
  • 8.4. Improvement In Quality Of Life After CAR T-Cell Therapy

9. CAR-T Therapy Market Trends And Strategies

  • 9.1. Remodeled CAR-T Cell Therapy For Fewer Side Effects
  • 9.2. Off-The-Shelf Allogeneic CAR-T Therapy For Improved Treatment
  • 9.3. Next-Generation CAR-T Cells For Treatment Of High-Grade Glioma
  • 9.4. Machine Learning And Artificial Intelligence To Optimize Future CAR-T Therapy
  • 9.5. Collaborating With Technology Companies For Advanced Technologies
  • 9.6. Growing Partnerships For Promoting CAR-T Therapy Market

10. CAR-T Therapy Market, COVID Impact Analysis

  • 10.1. Impact On Global CAR-T Therapy
  • 10.2. Impact On Global CAR-T Therapy Clinical Trials
  • 10.3. Impact On Leading Global Oncology Companies

11. Global CAR-T Therapy Market Size And Growth

  • 11.1. Historic Market Growth, 2015 - 2019, Value ($ Million)
    • 11.1.1. Drivers Of The Market 2015 - 2019
    • 11.1.2. Restraints On The Market 2015 - 2019
  • 11.2. Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
    • 11.2.1. Drivers Of The Market 2019 - 2023
    • 11.2.2. Restraints On The Market 2019 - 2023

12. Global CAR-T Therapy Market Segmentation

  • 12.1. Global CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 12.1.1. Diffuse Large B-Cell Lymphoma
    • 12.1.2. Acute Lymphoblastic Leukemia
    • 12.1.3. Follicular Lymphoma
    • 12.1.4. Multiple Myeloma
    • 12.1.5. Chronic Lymphocytic Leukemia
    • 12.1.6. Others
  • 12.2. Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 12.2.1. CD19
    • 12.2.2. BCMA
    • 12.2.3. Other Target Antigen
    • 12.2.4. CD22

13. CAR-T Therapy Market, Regional And Country Analysis

  • 13.1. Global CAR-T Therapy Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.2. Global CAR-T Therapy Market, By Country, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

14. Asia-Pacific CAR-T Therapy Market

  • 14.1. Asia-Pacific CAR-T Therapy Market Overview
    • 14.1.1. Region Information
    • 14.1.2. Market Information
    • 14.1.3. Impact of COVID-19
    • 14.1.4. Background Information
    • 14.1.5. Government Initiatives
    • 14.1.6. Regulations
    • 14.1.7. Regulatory Bodies
    • 14.1.8. Major Associations
    • 14.1.9. Taxes Levied
    • 14.1.10. Corporate Tax Structure
    • 14.1.11. Investment
    • 14.1.12. Major Companies
  • 14.2. Asia-Pacific CAR-T Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 14.3. Asia-Pacific CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 14.4. Asia-Pacific CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 14.5. Asia-Pacific CAR-T Therapy Market: Country Analysis
  • 14.6. China CAR-T Therapy Market
  • 14.7. China CAR-T Therapy Market Overview
    • 14.7.1. Country Information
    • 14.7.2. Market Information
    • 14.7.3. Impact of COVID-19
    • 14.7.4. Background Information
    • 14.7.5. Government Initiatives
    • 14.7.6. Regulations
    • 14.7.7. Regulatory Bodies
    • 14.7.8. Major Associations
    • 14.7.9. Taxes Levied
    • 14.7.10. Corporate Tax Structure
    • 14.7.11. Investment
    • 14.7.12. Major Companies
  • 14.8. China CAR-T Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 14.9. China CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 14.10. China CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 14.11. India CAR-T Therapy Market
  • 14.12. India CAR-T Therapy Market Overview
    • 14.12.1. Country Information
    • 14.12.2. Market Information
    • 14.12.3. Impact of COVID-19
    • 14.12.4. Background Information
    • 14.12.5. Government Initiatives
    • 14.12.6. Regulations
    • 14.12.7. Regulatory Bodies
    • 14.12.8. Major Associations
    • 14.12.9. Taxes Levied
    • 14.12.10. Corporate Tax Structure
    • 14.12.11. Investment
    • 14.12.12. Major Companies
  • 14.13. India CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 14.14. India CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 14.15. Japan CAR-T Therapy Market
  • 14.16. Japan CAR-T Therapy Market Overview
    • 14.16.1. Country Information
    • 14.16.2. Market Information
    • 14.16.3. COVID-19 Impact
    • 14.16.4. Background Information
    • 14.16.5. Government Initiatives
    • 14.16.6. Regulations
    • 14.16.7. Regulatory Bodies
    • 14.16.8. Major Associations
    • 14.16.9. Taxes Levied
    • 14.16.10. Corporate Tax Structure
    • 14.16.11. Investment
    • 14.16.12. Major Companies
  • 14.17. Japan CAR-T Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 14.18. Japan CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 14.19. Japan CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 14.20. Australia CAR-T Therapy Market
  • 14.21. Australia CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 14.22. Australia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 14.23. Indonesia CAR-T Therapy Market
  • 14.24. Indonesia CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 14.25. Indonesia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 14.26. South Korea CAR-T Therapy Market
  • 14.27. South Korea CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 14.28. South Korea CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

15. Western Europe CAR-T Therapy Market

  • 15.1. Western Europe CAR-T Therapy Market Overview
    • 15.1.1. Region Information
    • 15.1.2. Market Information
    • 15.1.3. Impact of COVID-19
    • 15.1.4. Background Information
    • 15.1.5. Government Initiatives
    • 15.1.6. Regulations
    • 15.1.7. Regulatory Bodies
    • 15.1.8. Major Associations
    • 15.1.9. Taxes Levied
    • 15.1.10. Corporate Tax Structure
    • 15.1.11. Investments
    • 15.1.12. Major Companies
  • 15.2. Western Europe CAR-T Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 15.3. Western Europe CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 15.4. Western Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 15.5. Western Europe CAR-T Therapy Market: Country Analysis
  • 15.6. UK CAR-T Therapy Market
  • 15.7. UK CAR-T Therapy Market Overview
    • 15.7.1. Country Information
    • 15.7.2. Market Information
    • 15.7.3. Impact of COVID-19
    • 15.7.4. Background Information
    • 15.7.5. Government Initiatives
    • 15.7.6. Regulations
    • 15.7.7. Regulatory Bodies
    • 15.7.8. Associations
    • 15.7.9. Taxes Levied
    • 15.7.10. Corporate Tax Structure
    • 15.7.11. Major Companies
  • 15.8. UK CAR-T Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 15.9. UK CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 15.10. UK CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 15.11. Germany CAR-T Therapy Market
  • 15.12. Germany CAR-T Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 15.13. Germany CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 15.14. Germany CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 15.15. France CAR-T Therapy Market
  • 15.16. France CAR-T Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 15.17. France CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 15.18. France CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

16. Eastern Europe CAR-T Therapy Market

  • 16.1. Eastern Europe CAR-T Therapy Market Overview
    • 16.1.1. Region Information
    • 16.1.2. Market Information
    • 16.1.3. Impact of COVID-19
    • 16.1.4. Background Information
    • 16.1.5. Government Initiatives
    • 16.1.6. Regulations
    • 16.1.7. Regulatory Bodies
    • 16.1.8. Associations
    • 16.1.9. Taxes Levied
    • 16.1.10. Corporate Tax Structure
    • 16.1.11. Investments
    • 16.1.12. Major Companies
  • 16.2. Eastern Europe CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 16.3. Eastern Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 16.4. Eastern Europe CAR-T Therapy Market: Country Analysis
  • 16.5. Russia CAR-T Therapy Market
  • 16.6. Russia CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 16.7. Russia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

17. North America CAR-T Therapy Market

  • 17.1. North America CAR-T Therapy Market Overview
    • 17.1.1. Region Information
    • 17.1.2. Impact Of COVID-19
    • 17.1.3. Market Information
    • 17.1.4. Background Information
    • 17.1.5. Government Initiatives
    • 17.1.6. Regulations
    • 17.1.7. Regulatory Bodies
    • 17.1.8. Major Associations
    • 17.1.9. Taxes Levied
    • 17.1.10. Corporate Tax Structure
    • 17.1.11. Investments
    • 17.1.12. Major Companies
  • 17.2. North America CAR-T Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.3. North America CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.4. North America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 17.5. North America CAR-T Therapy Market: Country Analysis
  • 17.6. USA CAR-T Therapy Market
  • 17.7. USA CAR-T Therapy Market Overview
    • 17.7.1. Country Information
    • 17.7.2. Impact Of COVID-19
    • 17.7.3. Market Information
    • 17.7.4. Background Information
    • 17.7.5. Government Initiatives
    • 17.7.6. Regulations
    • 17.7.7. Regulatory Bodies
    • 17.7.8. Major Associations
    • 17.7.9. Corporate Tax Structure
    • 17.7.10. Investments
    • 17.7.11. Major Companies
  • 17.8. USA CAR-T Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.9. USA CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.10. USA CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

18. South America CAR-T Therapy Market

  • 18.1. South America CAR-T Therapy Market Overview
    • 18.1.1. Region Information
    • 18.1.2. COVID Impact
    • 18.1.3. Market Information
    • 18.1.4. Background Information
    • 18.1.5. Government Initiatives
    • 18.1.6. Regulations
    • 18.1.7. Regulatory Bodies
    • 18.1.8. Major Associations
    • 18.1.9. Taxes Levied
    • 18.1.10. Corporate Tax Structure
    • 18.1.11. Major Companies
  • 18.2. South America CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.3. South America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.4. South America CAR-T Therapy Market: Country Analysis
  • 18.5. Brazil CAR-T Therapy Market
  • 18.6. Brazil CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.7. Brazil CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

19. Middle East CAR-T Therapy Market

  • 19.1. Middle East CAR-T Therapy Market Overview
    • 19.1.1. Region Information
    • 19.1.2. Market Information
    • 19.1.3. Impact of COVID-19
    • 19.1.4. Background Information
    • 19.1.5. Government Initiatives
    • 19.1.6. Regulations
    • 19.1.7. Regulatory Bodies
    • 19.1.8. Major Associations
    • 19.1.9. Investments
    • 19.1.10. Taxes Levied
    • 19.1.11. Corporate Tax Structure
    • 19.1.12. Major Companies
  • 19.2. Middle East CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 19.3. Middle East CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

20. Africa CAR-T Therapy Market

  • 20.1. Africa CAR-T Therapy Market Overview
    • 20.1.1. Region Information
    • 20.1.2. Market Information
    • 20.1.3. Impact Of COVID-19
    • 20.1.4. Background Information
    • 20.1.5. Government Initiatives
    • 20.1.6. Regulations
    • 20.1.7. Regulatory Bodies
    • 20.1.8. Major Associations
    • 20.1.9. Taxes Levied
    • 20.1.10. Corporate Tax Structure
    • 20.1.11. Major Companies
  • 20.2. Africa CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 20.3. Africa CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

21. Global CAR-T Therapy Market Competitive Landscape

  • 21.1. Company Profiles
  • 21.2. Gilead Sciences
    • 21.2.1. Company Overview
    • 21.2.2. Products And Services
    • 21.2.3. Business Strategy
    • 21.2.4. Financial Overview
  • 21.3. Novartis AG
    • 21.3.1. Company Overview
    • 21.3.2. Products And Services
    • 21.3.3. Business Strategy
    • 21.3.4. Financial Overview

22. CAR-T Therapy Pipeline Analysis

  • 22.1. Comparison Of The Landscape Of Active Trials Of Cancer Cell Therapies In 2020
  • 22.2. CAR T-Cell Therapy, Number Of Active Trials By Cancer Type
  • 22.3. CAR T-Cell Therapy, Number Of Active Trials By Cancer Type
  • 22.4. Global CAR-T Cell Therapy By Trial Site
  • 22.5. Number of Molecules In Cancer Clinical Trails, By Target
  • 22.6. CAR-T Cell Therapy Pipeline Analysis

23. Key Mergers And Acquisitions In The CAR-T Therapy Market

  • 23.1. ResTORbio Merged With Adicet Bio
  • 23.2. Astellas Pharma Acquired Xyphos Biosciences
  • 23.3. Bristol Myers Squibb Acquired Celgene Corporation
  • 23.4. Celgene Acquired Juno Therapeutics
  • 23.5. Gilead Sciences Acquired Cell Design Labs
  • 23.6. Gilead Sciences Acquired Kite Pharma

24. CAR-T Therapy Market Opportunities And Strategies

  • 24.1. Global CAR-T Therapy Market In 2023 - Countries Offering Most New Opportunities
  • 24.2. Global CAR-T Therapy Market In 2023 - Segments Offering Most New Opportunities
  • 24.3. Global CAR-T Therapy Market In 2023 - Growth Strategies
    • 24.3.1. Market Trend Based Strategies
    • 24.3.2. Competitor Strategies

25. CAR-T Therapy Market, Conclusions And Recommendations

  • 25.1. Conclusions
  • 25.2. Recommendations
    • 25.2.1. Product
    • 25.2.2. Price
    • 25.2.3. Place
    • 25.2.4. Promotion
    • 25.2.5. People

26. Appendix

  • 26.1. Market Data Sources
  • 26.2. Research Methodology
  • 26.3. Currencies
  • 26.4. Research Inquiries
  • 26.5. The Business Research Company
  • 26.6. Copyright and Disclaimer
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.